Diencephalic versus Hippocampal Amnesia in Alzheimer's Disease: The Possible Confabulation-Misidentification Phenotype.


Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2023
Historique:
pubmed: 29 11 2022
medline: 11 1 2023
entrez: 28 11 2022
Statut: ppublish

Résumé

Alzheimer's disease (AD) is clinically heterogeneous, including the classical-amnesic (CA-) phenotype and some variants. We aim to describe a further presentation we (re)named confabulation-misidentification (CM-) phenotype. We performed a retrospective longitudinal case-series study of 17 AD outpatients with the possible CM-phenotype (CM-ADs). Then, in a cross-sectional study, we compared the CM-ADs to a sample of 30 AD patients with the CA-phenotype (CA-ADs). The primary outcome was the frequency of cognitive and behavioral features. Data were analyzed as differences in percentage by non-parametric Chi Square and mean differences by parametric T-test. Anterograde amnesia (100%) with early confabulation (88.2%), disorientation (88.2%) and non-infrequently retrograde amnesia (64.7%) associated with reduced insight (88.2%), moderate prefrontal executive impairment (94.1%) and attention deficits (82.3%) dominated the CM-phenotype. Neuropsychiatric features with striking misidentification (52.9%), other less-structured delusions (70.6%), and brief hallucinations (64.7%) were present. Marked behavioral disturbances were present early in some patients and very common at later stages. At the baseline, the CM-ADs showed more confabulation (p < 0.001), temporal disorientation (p < 0.02), misidentification (p = 0.013), other delusions (p = 0.002), and logorrhea (p = 0.004) than the CA-ADs. In addition, more social disinhibition (p = 0.018), reduction of insight (p = 0.029), and hallucination (p = 0.03) persisted at 12 months from baseline. Both the CA- and CM-ADs showed anterior and medial temporal atrophy. Compared to HCs, the CM-ADs showed more right fronto-insular atrophy, while the CA-ADs showed more dorsal parietal, precuneus, and right parietal atrophy. We described an AD phenotype resembling diencephalic rather than hippocampal amnesia and overlapping the past-century description of presbyophrenia.

Sections du résumé

BACKGROUND
Alzheimer's disease (AD) is clinically heterogeneous, including the classical-amnesic (CA-) phenotype and some variants.
OBJECTIVE
We aim to describe a further presentation we (re)named confabulation-misidentification (CM-) phenotype.
METHODS
We performed a retrospective longitudinal case-series study of 17 AD outpatients with the possible CM-phenotype (CM-ADs). Then, in a cross-sectional study, we compared the CM-ADs to a sample of 30 AD patients with the CA-phenotype (CA-ADs). The primary outcome was the frequency of cognitive and behavioral features. Data were analyzed as differences in percentage by non-parametric Chi Square and mean differences by parametric T-test.
RESULTS
Anterograde amnesia (100%) with early confabulation (88.2%), disorientation (88.2%) and non-infrequently retrograde amnesia (64.7%) associated with reduced insight (88.2%), moderate prefrontal executive impairment (94.1%) and attention deficits (82.3%) dominated the CM-phenotype. Neuropsychiatric features with striking misidentification (52.9%), other less-structured delusions (70.6%), and brief hallucinations (64.7%) were present. Marked behavioral disturbances were present early in some patients and very common at later stages. At the baseline, the CM-ADs showed more confabulation (p < 0.001), temporal disorientation (p < 0.02), misidentification (p = 0.013), other delusions (p = 0.002), and logorrhea (p = 0.004) than the CA-ADs. In addition, more social disinhibition (p = 0.018), reduction of insight (p = 0.029), and hallucination (p = 0.03) persisted at 12 months from baseline. Both the CA- and CM-ADs showed anterior and medial temporal atrophy. Compared to HCs, the CM-ADs showed more right fronto-insular atrophy, while the CA-ADs showed more dorsal parietal, precuneus, and right parietal atrophy.
CONCLUSION
We described an AD phenotype resembling diencephalic rather than hippocampal amnesia and overlapping the past-century description of presbyophrenia.

Identifiants

pubmed: 36442200
pii: JAD220919
doi: 10.3233/JAD-220919
pmc: PMC9881034
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

363-388

Références

Neurocase. 2016 Oct;22(5):451-460
pubmed: 27705090
Neuroimage Clin. 2020;28:102453
pubmed: 33045537
Psychol Med. 1986 May;16(2):267-75
pubmed: 3726003
Neurology. 2013 Jan 29;80(5):496-503
pubmed: 23359374
Brain. 2019 May 1;142(5):1458-1470
pubmed: 30879030
Alcohol Alcohol. 2009 Mar-Apr;44(2):148-54
pubmed: 19151162
Brain. 2016 Apr;139(Pt 4):1211-25
pubmed: 26936938
Alzheimers Res Ther. 2013 Jan 09;5(1):1
pubmed: 23302773
Ital J Neurol Sci. 1996 Aug;17(4):305-9
pubmed: 8915764
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Brain. 2009 Jan;132(Pt 1):204-12
pubmed: 18829697
Front Psychol. 2020 Sep 29;11:553886
pubmed: 33117224
Alzheimers Dement. 2017 Aug;13(8):870-884
pubmed: 28259709
Alzheimers Res Ther. 2019 Oct 15;11(1):84
pubmed: 31615545
Neuropsychologia. 2006;44(10):1697-707
pubmed: 16697019
Nat Rev Neurol. 2012 Aug;8(8):451-64
pubmed: 22801974
Neurosci Biobehav Rev. 2012 Nov;36(10):2274-87
pubmed: 22910677
Alzheimers Dement. 2011 May;7(3):270-9
pubmed: 21514249
Br J Psychiatry. 2009 Mar;194(3):212-9
pubmed: 19252147
Gerontologist. 1969 Autumn;9(3):179-86
pubmed: 5349366
Int J Geriatr Psychiatry. 2008 Feb;23(2):170-7
pubmed: 17607801
Arch Gen Psychiatry. 1997 Mar;54(3):257-63
pubmed: 9075466
Brain. 2009 Apr;132(Pt 4):1102-11
pubmed: 18952676
J Cogn Neurosci. 2007 Jul;19(7):1081-8
pubmed: 17583985
Arch Neurol. 1975 Sep;32(9):632-7
pubmed: 1164215
Nat Rev Neurosci. 2003 Aug;4(8):662-71
pubmed: 12894241
Psychiatry Clin Neurosci. 2017 Jan;71(1):61-69
pubmed: 27981677
Neurol Sci. 2002 Mar;22(6):443-7
pubmed: 11976975
Cogn Neuropsychiatry. 2010 Jan;15(1):14-37
pubmed: 19753493
Br J Psychiatry. 1982 Jun;140:566-72
pubmed: 7104545
Cortex. 2000 Sep;36(4):561-77
pubmed: 11059455
J Geriatr Psychiatry Neurol. 2007 Mar;20(1):34-40
pubmed: 17341769
Ital J Neurol Sci. 1987 Dec;Suppl 8:1-120
pubmed: 3330072
Alzheimer Dis Assoc Disord. 2016 Oct-Dec;30(4):331-337
pubmed: 26859554
Mech Ageing Dev. 2019 Mar;178:41-45
pubmed: 30658061
Neurol Sci. 2013 May;34(5):749-54
pubmed: 22689311
Gerontologist. 1970 Spring;10(1):20-30
pubmed: 5420677
Am J Psychiatry. 2003 Feb;160(2):341-9
pubmed: 12562582
Cortex. 2007 Oct;43(7):835-45
pubmed: 17941342
Neurology. 1994 Dec;44(12):2308-14
pubmed: 7991117
Br J Psychiatry. 1985 Jul;147:76-9
pubmed: 4063614
Neurology. 2015 Oct 6;85(14):1240-9
pubmed: 26354982
BMC Geriatr. 2010 Nov 30;10:87
pubmed: 21118498
Arch Neurol. 2012 Feb;69(2):169-75
pubmed: 21987392
Alzheimer Dis Assoc Disord. 2008 Apr-Jun;22(2):163-9
pubmed: 18525289
J Int Neuropsychol Soc. 2010 Nov;16(6):967-74
pubmed: 20946707
Brain. 2021 Apr 12;144(3):999-1012
pubmed: 33501939
Funct Neurol. 1987 Apr-Jun;2(2):189-94
pubmed: 3666548
Appl Neuropsychol Adult. 2021 May-Jun;28(3):282-296
pubmed: 31269816
Cortex. 2013 Jun;49(6):1541-52
pubmed: 23507236
Alzheimers Dement (Amst). 2017 Mar 06;6:201-209
pubmed: 28349119
Dement Geriatr Cogn Dis Extra. 2020 Mar 26;10(1):56-62
pubmed: 32308668
Neurology. 2008 Oct 14;71(16):1227-34
pubmed: 18633132
Brain. 2010 Apr;133(Pt 4):1155-62
pubmed: 20147454
J Geriatr Psychiatry Neurol. 1993 Jan-Mar;6(1):25-8
pubmed: 8422267
Ital J Neurol Sci. 1987 Dec;8(6):539-48
pubmed: 3429213
Dement Geriatr Cogn Dis Extra. 2011 Jan;1(1):372-80
pubmed: 22187544
Neurosci Biobehav Rev. 2013 Sep;37(8):1724-37
pubmed: 23850593
Alzheimers Res Ther. 2018 May 24;10(1):46
pubmed: 29793546
Brain. 2015 Sep;138(Pt 9):2732-49
pubmed: 26141491
Alzheimers Dement. 2011 May;7(3):263-9
pubmed: 21514250
J Clin Exp Neuropsychol. 2001 Apr;23(2):172-84
pubmed: 11309671
Parkinsonism Relat Disord. 2013 Feb;19(2):227-31
pubmed: 23182311
Cogn Behav Neurol. 2009 Jun;22(2):81-8
pubmed: 19506423
Front Psychol. 2013 May 30;4:314
pubmed: 23755038
Arch Clin Neuropsychol. 2007 Nov;22(8):949-56
pubmed: 17913452
Arch Neurol. 2010 Aug;67(8):949-56
pubmed: 20697045
Am J Psychiatry. 2005 Nov;162(11):2022-30
pubmed: 16263838
Am J Geriatr Psychiatry. 2003 Jul-Aug;11(4):406-13
pubmed: 12837669
Neuropsychiatr Dis Treat. 2017 Nov 27;13:2875-2890
pubmed: 29225466

Auteurs

Carlo Abbate (C)

Istituto Palazzolo, IRCCS Fondazione Don Carlo Gnocchi Onlus, Milan, Italy.

Pietro D Trimarchi (PD)

Istituto Palazzolo, IRCCS Fondazione Don Carlo Gnocchi Onlus, Milan, Italy.

Giorgio G Fumagalli (GG)

Neurology Unit, IRCCS Fondazione Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.

Alessia Gallucci (A)

Istituto Palazzolo, IRCCS Fondazione Don Carlo Gnocchi Onlus, Milan, Italy.
Ph.D. Program in Neuroscience, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.

Emanuele Tomasini (E)

Istituto Palazzolo, IRCCS Fondazione Don Carlo Gnocchi Onlus, Milan, Italy.

Stefania Fracchia (S)

Istituto Palazzolo, IRCCS Fondazione Don Carlo Gnocchi Onlus, Milan, Italy.

Isabella Rebecchi (I)

Istituto Palazzolo, IRCCS Fondazione Don Carlo Gnocchi Onlus, Milan, Italy.

Elisabetta Morello (E)

Istituto Palazzolo, IRCCS Fondazione Don Carlo Gnocchi Onlus, Milan, Italy.

Anna Fontanella (A)

Istituto Palazzolo, IRCCS Fondazione Don Carlo Gnocchi Onlus, Milan, Italy.

Paola M R Parisi (PMR)

Istituto Palazzolo, IRCCS Fondazione Don Carlo Gnocchi Onlus, Milan, Italy.

Federica Tartarone (F)

Istituto Palazzolo, IRCCS Fondazione Don Carlo Gnocchi Onlus, Milan, Italy.

Fabrizio Giunco (F)

Istituto Palazzolo, IRCCS Fondazione Don Carlo Gnocchi Onlus, Milan, Italy.

Simona Ciccone (S)

Geriatric Unit, IRCCS Fondazione Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.

Paola Nicolini (P)

Geriatric Unit, IRCCS Fondazione Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.

Tiziano Lucchi (T)

Geriatric Unit, IRCCS Fondazione Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.

Beatrice Arosio (B)

Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.

Silvia Inglese (S)

Geriatric Unit, IRCCS Fondazione Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.

Paolo D Rossi (PD)

Geriatric Unit, IRCCS Fondazione Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH